All public logs

Combined display of all available logs of Glioblastoma Treatments. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 04:52, 24 March 2024 Lazy talk contribs created page ABT-414 (Created page with "{{TreatmentInfo |drug_name=ABT-414 |FDA_approval=No |used_for=Targeting EGFR overexpressing glioblastoma cells |clinical_trial_phase=Phase 1 |common_side_effects=Eye toxicities, especially blurred vision |OS_with=Not reached at a median follow-up of 5.8 months |PFS_with=6.1 months for all patients, 5.9 months for EGFR amplified patients |usefulness_rating=2 |notes=ABT-414, an antibody-drug conjugate, selectively targets EGFR expressing tumor cells with minimal effects on...")